Shenzhen Kangtai Biological Products Co Ltd (300601)
Shenzhen Stock Exchange · China · prices in CNY · close of 20 Oct 2026
Key indicators
| Last close | CNY 12.38 |
|---|---|
| 52-week range | 10.70 – 17.71 |
| Return, 1 month / 3 months | +5.4% / −2.3% |
| Return, 1 year / 3 years | −24.4% / −54.8% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 39.2% |
| Worst drawdown (1 year) | -37.1% |
| Average daily value traded | 280.81M CNY |
| Dividend yield | 0.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Shenzhen Kangtai Biological Products is a Chinese biopharmaceutical company that develops and makes vaccines. Its main products are preventive vaccines, including recombinant hepatitis B vaccine, and it also works on other immunization products for infectious diseases. The company serves public health and medical markets in China, supplying doses for routine vaccination programmes through health authorities and medical channels. It is based in Shenzhen, where it carries out research, production and quality control of its biological products.
On this site Shenzhen Kangtai Biological Products Co Ltd appears as a stock on the Shenzhen Stock Exchange (China), code 300601, with prices in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Shenzhen Kangtai Biological Products Co Ltd (300601) trades on the Shenzhen Stock Exchange in China. It last closed at CNY 12.38 on 20 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 689 of 2,821 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 24.4% and over the last three months it fell 2.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shenzhen Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -8.4% | ||
| From 52-week high | -29.0% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -2.3% | ||
| 6-month return | -11.4% | ||
| 12-month return, skipping the last month | -28.2% | ||
| Stability (higher is calmer) | 75 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.1% | ||
| Liquidity | 73 · Strong | Trades actively. | |
| Average daily value traded | 280.81M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.3% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.3% |
|---|---|
| 1 month | +5.4% |
| 3 months | −2.3% |
| 6 months | −11.4% |
| 1 year | −24.4% |
| 3 years | −54.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 12.70 / 13.51 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Jun 2026 | CNY 0.0350 |
| 6 Jun 2025 | CNY 0.0900 |
| 14 Jun 2024 | CNY 0.2000 |
| 13 Oct 2023 | CNY 0.1800 |
| 2 Jun 2022 | CNY 1.3600 |
| 29 Sep 2021 | CNY 0.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shenzhen Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.